Showing results (241-250 of 782) with videos related to
Sort By:
Pageof 79
Frontiers in Immunology|July 7, 2025
C3d-targeted complement inhibitors to correct complement dysregulation in aHUS patientsValeria Guaschino, Donata Santarsiero, Sara Gastoldi, et al.Diabetes|June 5, 2013
ADAMTS13 predicts renal and cardiovascular events in type 2 diabetic patients and response to therapyErica Rurali, Marina Noris, Antonietta Chianca, et al.Journal of the American Society of Nephrology : JASN|September 7, 2014
Paricalcitol for secondary hyperparathyroidism in renal transplantationMatias Trillini, Monica Cortinovis, Piero Ruggenenti, et al.Plos One|March 7, 2012
Measuring and estimating GFR and treatment effect in ADPKD patients: results and implications of a longitudinal cohort studyPiero Ruggenenti, Flavio Gaspari, Antonio Cannata, et al.Lancet (London, England)|June 4, 2013
Kidney failure: aims for the next 10 years and barriers to successGiuseppe Remuzzi, Ariela Benigni, Fredric O Finkelstein, et al.Kidney International|August 13, 2010
Sirolimus for calcineurin inhibitors in organ transplantation: contraPaolo Cravedi, Piero Ruggenenti, Giuseppe RemuzziJournal of the American Society of Nephrology : JASN|December 25, 2003
Transplant renal artery stenosisSimona Bruno, Giuseppe Remuzzi, Piero RuggenentiCurrent Opinion in Nephrology and Hypertension|April 13, 2006
Progression of chronic kidney disease: insights from animal modelsCarla Zoja, Mauro Abbate, Giuseppe RemuzziKidney International|May 20, 2003
Retarding progression of chronic renal disease: the neglected issue of residual proteinuriaPiero Ruggenenti, Annalisa Perna, Giuseppe Remuzzi, et al.Journal of Renal Care|January 24, 2009
Kidney failure stabilizes after an increase over 2 decadesPaolo Cravedi, Piero Ruggenenti, Giuseppe RemuzziPageof 79